Browsing Tag
Boston
61 posts
US heat wave puts 185 million under alerts as July 4 events are cancelled
A dangerous US heat wave has put 185 million people under alerts, cancelled July 4 events and strained power grids across major cities.
Could elsunersen become the asset that steadies Praxis Precision Medicines’ CNS pipeline?
Find out how Praxis’ FDA Breakthrough Therapy Designation for elsunersen could affect PRAX stock, rare epilepsy strategy and precision neuroscience today!
Why Trump’s proof-of-citizenship voting order just hit a major court wall
Trump’s proof-of-citizenship voting order faces a major court setback as judges, states and Congress clash over election authority.
US court dismisses Trump administration challenge to Los Angeles sanctuary-city policy
Los Angeles kept control of its city resources, but the Trump administration can amend its case. The sanctuary-city fight remains far from settled in court.
FIFA World Cup 2026 host cities explained: How US, Canada and Mexico will stage 104 matches
World Cup 2026 is a city operations test. Sixteen host markets must move fans, manage crowds and turn football into tourism value.
Tango Therapeutics (NASDAQ: TNGX) jumps 11% into May 11 earnings and pivotal pancreatic cancer data
Tango Therapeutics is up 22-fold from $1.04 in twelve months. The May 11 earnings print decides whether vopimetostat justifies the run or breaks it.
Seaport Therapeutics seeks $212m IPO as neuropsychiatry biotech window reopens
Seaport’s IPO tests biotech appetite before key depression data. Here’s why SPTX, PureTech, and psychiatry investors are watching.
Mauna Kea Technologies FY2025 results show why ALMKT is no longer just a restructuring story
Mauna Kea Technologies says FY2025 reset its balance sheet and reignited growth. Read what the debt cut, U.S. sales surge, and 2026 outlook mean.
Why Lilly’s $3.25bn Kelonia acquisition signals a manufacturing shift across the entire CAR-T landscape
Eli Lilly agrees to acquire Kelonia Therapeutics for up to $7B. What the iGPS in vivo CAR-T platform means for oncology and LLY investors. Read the analysis.
NHS England commits £237m to expand Community Diagnostic Centres as government targets record diagnostic output in 2026
The UK government commits £237 million to expand NHS Community Diagnostic Centres across England. What the investment means for waiting lists, care access, and NHS strategy. Read more.